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ABSTRACT
During late gestation, villi extend into the intestinal lumen to
dramatically increase the surface area of the intestinal epithelium,
preparing the gut for the neonatal diet. Incomplete development of
the intestine is the most common gastrointestinal complication in
neonates, but the causes are unclear. We provide evidence in mice
that Yin Yang 1 (Yy1) is crucial for intestinal villus development. YY1
loss in the developing endoderm had no apparent consequences
until late gestation, after which the intestine differentiated poorly and
exhibited severely stunted villi. Transcriptome analysis revealed that
YY1 is required for mitochondrial gene expression, and ultrastructural
analysis confirmed compromisedmitochondrial integrity in themutant
intestine. We found increased oxidative phosphorylation gene
expression at the onset of villus elongation, suggesting that aerobic
respirationmight function as a regulator of villus growth. Mitochondrial
inhibitors blocked villus growth in a fashion similar to Yy1 loss, thus
further linking oxidative phosphorylation with late-gestation intestinal
development. Interestingly, we find that necrotizing enterocolitis
patients also exhibit decreased expression of oxidative
phosphorylation genes. Our study highlights the still unappreciated
role of metabolic regulation during organogenesis, and suggests that
it might contribute to neonatal gastrointestinal disorders.
KEY WORDS: Intestinal organogenesis, YY1, Villus, Oxidative
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INTRODUCTION
Necrotizing enterocolitis (NEC) is the most common
gastrointestinal condition among newborns, affecting ∼7% of pre-
term infants with a mortality rate of 20-30% (Neu andWalker, 2011;
Zani and Pierro, 2015). The etiologies of NEC remain unclear, but
they are expected to be multi-factorial and correspond closely with
an underdeveloped intestine that is predisposed to deficiencies in
digestion, barrier function and immune defenses. The immature
intestine is susceptible to an excessive inflammatory response upon
exposure to diet and colonization of microbiota, and ultimately
manifests in necrosis of the tissue (Neu, 2014). Why a subset of pre-
term babies may present with an immature intestine is unclear,
necessitating a better understanding of intestinal development and
maturation.
The intestine arises from a specified field of endodermal tissue
that is shaped into a tube lined with a rapidly proliferating,
pseudostratified epithelium by embryonic day (E) 9.5 in mouse
(Grosse et al., 2011; Spence et al., 2011; Wells and Melton, 1999).
Over the next 6 days of development, proliferation in the epithelium
accompanies a tremendous expansion in the length and
circumference of the intestine. By E14.5-E16.5, condensations of
mesenchymal cells arise and serve as signaling centers that trigger
the overlying epithelium to withdraw from the cell cycle, undergo a
transition to a simple columnar morphology, and extend into
luminal projections called villi (Burns et al., 2004; Kaestner et al.,
1997; Madison et al., 2009; Mathan et al., 1976; Noah et al., 2011;
Pabst et al., 1997, 1999; Shyer et al., 2015; Walton et al., 2012,
2016). Cells between villi remain proliferative and will ultimately
undergo a morphological restructuring to form crypts of
Lieberkhün. Meanwhile, villus cells are postmitotic and express
genes appropriate to their differentiated function in secretion or
absorption; epithelial cells transit towards the villus tips, where they
ultimately delaminate into the lumen. A number of developmental
signaling molecules and transcriptional regulators have been
implicated in villus development (Choi et al., 2006; Kaestner
et al., 1997; Karlsson et al., 2000; Kim et al., 2007; Lepourcelet
et al., 2005; Madison et al., 2005; McLin et al., 2009;
Ormestad et al., 2006; Shyer et al., 2013; Spence et al., 2011; van
den Brink, 2007; Walker et al., 2014; Walton et al., 2012, 2016);
however, the role of metabolic regulators in villus development has
yet to be investigated.
Otto Warburg first recognized that cancer cells ferment much of
their glucose supply into lactate regardless of the presence of
oxygen, a phenomenon termed the Warburg effect or aerobic
glycolysis (Warburg et al., 1924). Recently it has become better
appreciated that metabolic shifts are also crucial in developmental
processes. At the earliest stages of life glycolysis is preferred, as
seen in the ESC-to-EpiSC transition (Zhou et al., 2012) and in the
switch from oxidative phosphorylation to glycolysis that
accompanies the conversion of differentiated cells into iPSCs
(Folmes et al., 2011; Shyh-Chang and Daley, 2013). Metabolic
processes have also recently been coupled to other developmental
transitions, including macrophage activation (Tannahill et al.,
2013), differentiation of mesenchymal and hematopoietic stem
cells, and in the transition of satellite stem cells in muscle (Bracha
et al., 2010; Chen et al., 2008; Qian et al., 2016; Takubo et al., 2013;
Tormos et al., 2011; reviewed by Shyh-Chang et al., 2013). These
studies highlight that metabolic processes are potentially driving
regulators of development. In the adult intestine, a shift fromReceived 23 March 2016; Accepted 25 August 2016
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glycolysis to oxidative phosphorylation correlates with the cell
position along the crypt-to-villus axis (Stringari et al., 2012), and
the suckling-weaning transition coincides with metabolic changes
that are probably related to dietary changes (Mould et al., 2015).
However, a role for metabolism has not been explored in intestinal
organogenesis.
The transcription factor YY1 has been shown to play a significant
role during cell differentiation, proliferation, and other major
biological processes such as V(D)J rearrangement (Atchison,
2014), viral gene repression (Shi et al., 1991) and X inactivation
(Jeon and Lee, 2011). YY1 also regulates mitochondrial genes, as it
has been implicated in the maintenance of mitochondrial structure
and function as well as in regulating oxidative phosphorylation and
other ATP-yielding processes (Blattler et al., 2012; Perekatt et al.,
2014). The molecular pathway through which YY1 acts to regulate
these functions is unclear. Some studies have shown that YY1
functions downstream of the mTOR complex and PPARGC1α (also
known as PGC1α) to control the transcription of thesemitochondrial
genes (Cunningham et al., 2007). mTOR plays a crucial role in
intestinal regeneration after injury in adult mice, whereas mice with
genetic ablation of mTOR components during mid-gestation have
minimal deficiencies in normal adult homeostasis, particularly in the
proximal gut, where villi are most pronounced (Faller et al., 2015;
Sampson et al., 2016). However, the consequence of mTOR or YY1
disruption in early intestinal development has not been closely
examined. Elucidating YY1 function in intestinal development
therefore presents an opportunity to understand how the loss of a
metabolic regulator might impact organogenesis in this tissue.
In the current study, we observe a regulatory shift in expression of
oxidative phosphorylation genes that coincides with the process of
villus formation. Genetic ablation of Yy1 in the developing intestinal
epithelium results in a failure to elevate oxidative phosphorylation
gene expressionand in compromised villus elongation. To substantiate
the link between aerobic metabolism and intestinal organogenesis, we
show that pharmacological inhibition of the electron transport chain
similarly compromises villus development. Finally, we demonstrate
that expression of oxidative phosphorylation genes is decreased in
NEC patient intestines, and propose that a deficient metabolic
transition could underlie this prevalent neonatal condition.
RESULTS
YY1 expression in the developing endoderm is required for
villus development
To characterize the role of YY1 during intestinal development, we
employed the Shh-cre driver, which is expressed throughout the
intestinal epithelium starting at ∼E9.5 (Harris-Johnson et al., 2009).
At E18.5, Yy1f/f; Shh-cre pups (hereafter referred to as YY1KO)
exhibited gross morphological defects with a translucent and
distended intestine, indicating an underdeveloped intestine
compared with littermate controls (Fig. 1A). Uniform, epithelial-
specific YY1 loss was confirmed by immunostaining (Fig. 1G-K).
Despite YY1 loss early in intestinal development, no morphological
phenotype was observed until late gestation. We first observed
reduced villus growth at E16.5 in Yy1 mutant embryos, although
villus height at this stage was not significantly shorter (Fig. 1B-E).
However, by E18.5, a dramatic failure of villus elongation was
evident (Fig. 1F) and villus height in the mutants was significantly
reduced compared with littermate controls (Fig. 1L), a pattern
consistent from duodenum to ileum (Fig. S1).
To further explore intestinal development upon YY1 loss, we
examined proliferation and differentiation markers. Yy1 mutants
exhibited an enterocyte differentiation defect as seen by reduced
alkaline phosphatase staining (Fig. 2A, Fig. S2A), whereas periodic
acid-Schiff staining suggested similar goblet cell development in
mutants and controls (Fig. 2B, Fig. S2B). To evaluate whether the
villus growth defect could be attributed to reduced proliferation
or increased cell death, we assayed proliferation using Ki67
(Fig. 2C-E, Fig. S2C) and BrdU (Fig. 2F-H), and found
proliferation to be unaffected upon YY1 loss (Fig. S2G). Also,
we found no significant apoptosis upon YY1 loss, as measured by
cleaved caspase 3 staining (Fig. S2D). The epithelium also had
fewer cells (Fig. S2F), suggesting that the villus elongation deficit
was not attributable to pressure accumulating in the lumen. To better
understand why the Yy1 mutant epithelium had fewer cells, we
traced epithelial cells over time using BrdU pulse-chase labeling at
1, 48 and 96 h of chase time, concluding at E18.5. In both Yy1
mutants and control littermates, BrdU cells migrated towards villi
tips. However, BrdU-labeled cells were eliminated from the mutant
epithelium more rapidly, possibly owing to the shorter villus
length, which would shorten their transit path to the villus tip
(Fig. 2I, Fig. S2E).
Taken together, our results indicate that YY1 is dispensable for
proliferation in the developing intestinal epithelium, but is clearly
required for proper differentiation of enterocytes and elaboration of
full villi.
Villogenesis initiates despite loss of YY1
To better understand why villi are stunted in YY1KO animals, we
evaluated whether initiation of villogenesis is disrupted. We stained
for the presence of PDGFRα-expressing mesenchymal clusters,
which form the signaling foci from which villus development
proceeds (Walton et al., 2012). PDGFRα clusters were clearly
present in the Yy1 mutants at E16.5 (Fig. 3A-D), suggesting that
villogenesis initiates normally. These results thereby highlight that
villogenesis initiates properly in the absence of YY1, yet extension
of the nascent villi into the lumen is subsequently compromised.
YY1 acts independently of mTOR signaling in villus
development
A recent study inactivating mTOR signaling during intestinal
development did not compromise duodenal villus length in the adult
(Sampson et al., 2016); however, villus formation was not
investigated during early intestinal development. Since YY1 has
been demonstrated to function downstream of mTOR (Cunningham
et al., 2007), we queried whether disruption of mTOR signaling in
the developing intestine would yield a similar villus elongation
defect as observed upon YY1 loss. We inhibited mTOR signaling in
the developing intestine using two approaches: pharmacologically,
with the mTOR complex 1 (mTORC1) inhibitor rapamycin; and
genetically, using conditional ablation of Rptor (RptorKO). Rptor is
an essential component of mTORC1 that is required for mTOR-
mediated nutrient sensing, and rapamycin destabilizes the mTOR-
Rptor complex (Kim et al., 2002). We confirmed mTOR signaling
inhibition via both approaches at E18.5 using western blot staining
of phosphorylated S6 kinase (pS6), a canonical mTOR target, in
whole gut tissues (Fig. S3A,B). However, villus length was
unaffected in RptorKO and rapamycin-treated embryos compared
with controls (Fig. 3E-H) and significantly longer than in YY1KO
(Fig. 1L, Fig. 3H). Thus, although mTOR may be involved in
regulating other intestinal processes (Faller et al., 2015; Sampson
et al., 2016), our findings suggest a dispensable role of mTOR in
villus development. This also indicates that, unlike YY1 function
downstream of mTOR in other tissues (Blattler et al., 2012), YY1
acts independently of mTOR in regulating villus growth.
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YY1 loss leads to mitochondrial dysfunction
To elucidate the underlying cause of deficient villus elongation in
the absence of Yy1, we performed transcriptome analysis at E15.5,
early in villus formation, immediately prior to when morphological
phenotypes were discernable in the mutant. Small intestinal
epithelial cells from E15.5 embryos were enriched by dissection
and purified using antibodies to the epithelial cell-specific marker
Epcam (Fig. 4A). Transcriptome analysis identified 800 unique
genes that were downregulated upon YY1 loss [log2 fold change
(FC)<−1, Benjamini-Hochberg adjusted P<0.05; Fig. 4B], as
confirmed by qRT-PCR for selected genes (Fig. S3C). Products of
these genes were enriched for localization to the brush border,
consistent with the deficient alkaline phosphatase activity ascribed
to this structure (Fig. 2A, Fig. S2A), and supporting the idea that
YY1 promotes maturation of the developing intestinal epithelium.
Mitochondrial function was the most strongly enriched attribute
of genes downregulated in YY1KO epithelia (Fig. 4C), and many of
these genes have been shown to bind YY1 via ChIP-seq (Table S1).
We therefore examined mitochondrial ultrastructure using
transmission electron microscopy (TEM), and revealed that Yy1
loss leads to defective mitochondrial morphology, with distended,
electron-poor inner membrane space, and disrupted cristae
(Fig. 4D). TEM also revealed that microvillus length was
significantly reduced (Fig. 4E,D, red boxes), consistent with
downregulation of genes associated with the brush border (Fig. 4C).
Together, transcriptomic analysis of E15.5 epithelium points to a
role for YY1 regulation of mitochondrial function, and suggests
that mitochondrial dysfunction disrupts proper villus growth and
maturation in the developing intestine.
A metabolic shift to increased oxidative phosphorylation is
required for villus development
Although mitochondrial structure was clearly dependent upon YY1
in the developing gut (Fig. 4D), it was surprising to find that a
Fig. 1. YY1 expression in the developing endoderm is required for villus development. (A) YY1 loss leads to an underdeveloped intestine at E18.5, with
mutant intestine being distended, translucent and devoid of villi. Yy1mutants have similar morphology to control littermates at E10.5 (B), E12.5 (C) and E14.5 (D),
subtle changes at E16.5 (E) and strikingly stunted villi at E18.5 (F) in the duodenum. YY1 immunostaining of duodenal sections shows specific and complete loss
of YY1 immunoreactivity in the intestinal epithelium of Cre+ animals at E10.5 (G), E12.5 (H), E14.5 (I), E16.5 (J) and E18.5 (K). Dashed lines highlight the border
between the epithelium and mesenchyme. (L) Villus height measurements are not dramatically altered in E16.5 duodenum (P=0.125, n=4) or ileum (P=0.026,
n=4). However, Yy1 mutants have drastically reduced villus height at E18.5, a pattern observed from duodenum (**P=3×10−6, n=4) to ileum (**P=1×10−4, n=2).
Error bars show s.e. Two-tailed t-tests were performed based on the results of an F-test for sample variances. Scale bars: 50 µm.
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phenotype only manifested itself ∼7 days after Shh-cre-mediated
deletion of Yy1 at E9.5, especially considering that Yy1 transcripts
(Fig. S4A) and protein levels (Fig. 1G-K) are fairly stable across
developmental time. Consistent with mitochondrial localization,
genes downregulated upon YY1 loss are also enriched for function
in oxidative phosphorylation (OxPhos, ranked second after
mitochondrial dysfunction in Ingenuity pathway analysis –
canonical pathways; P=1.02×10−10) and involved in all
complexes of the electron transport chain (ETC) (Fig. 5C). To
understand why reduction of OxPhos genes does not cause a
YY1KO phenotype prior to E16.5, we analyzed their expression
during stages of intestinal development (Kaiser et al., 2007).
Interestingly, OxPhos genes show a marked increase in expression
at ∼E16.5 in mouse intestine (Fig. 5A,B), coincident with the time
of the villus elongation phenotype in Yy1 mutants. Our analysis
thus reveals a shift in metabolic gene expression to OxPhos that
coincides with villus elongation. We further corroborated our
findings by showing that genes downregulated upon YY1 loss are
destined to increase at ∼E16.5 in the developing intestine
(Fig. S4B,C) and are enriched for mitochondrial function (Fig. 4C).
To determine whether mitochondrial function is compromised in
the Yy1 mutant epithelium, we performed assays of mitochondrial
activity, in situ, to separately query the activities of mitochondrial
complexes I and IV. In both cases, epithelial cells in the Yy1 mutant
were severely deficient in these activities compared with control
epithelial cells, whereas cells in the developing muscle and stroma
Fig. 2. YY1 loss compromises enterocyte differentiation but not cell proliferation. (A) Yy1mutant enterocytes exhibit diminished alkaline phosphatase (AP)
staining at E18.5, whereas goblet cell differentiation appears normal, as seen by periodic acid-Schiff (PAS) staining (B). Yy1 mutants have similar numbers of
proliferating cells, as seen by Ki67 (C-E) and BrdU (F-H) staining. (I) BrdU pulse-chase labeling suggests a more rapid elimination of mutant cells from the
epithelium (1 h control, n=2; 1 h mutant, n=2; 48 h control, n=4; 48 h mutant, n=3; 96 h control, n=4; 96 h mutant, n=3). Error bars represent s.e. All histological
staining and quantification were performed on duodenal regions. Scale bars: 50 µm.
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showed similar levels of mitochondrial complex activities (Fig. 5D,E,
Fig. S4D,E). As an indicator of mitochondrial mass, we performed
immunostaining and immunoblots for Tomm20. Consistent with the
distended mitochondria observed by TEM (Fig. 4D), Tomm20
immunoreactivity was dispersed in Yy1 mutant epithelial cells
(Fig. 5F). Additionally, western blot revealed that Tomm20 protein
levels are elevated in the mutant (Fig. 5G). Increased Tomm20 levels
might be a response to the energy demand sensed by the cells as a
result of compromised respiratory transport chain function. Together,
these assays are consistent with the gene expression analysis, and
indicate that OxPhos is compromised in the Yy1 mutant epithelium.
To test our hypothesis that OxPhos is indispensable to support the
metabolic requirements of a budding villus structure, we utilized an
explant culture system in which villus development can be observed
ex vivo (Walton et al., 2012). Intestine segments of developing
duodena were cultured in the presence or absence of the
mitochondrial inhibitors rotenone (inhibits ETC complex 1) or
oligomycin (inhibits complex 5) (Fig. 5C). Targeting these
complexes reduced the formation of villus structures and revealed
that ETC function is required for villus elongation (Fig. 6A-I), akin
to YY1 activity in vivo. These results suggest that increased aerobic
respiration is crucial to intestinal epithelial development,
specifically during late gestation and villus development. Notably,
the concentrations of ETC inhibitors used in this experiment did not
compromise cell proliferation (Fig. 6F-H) or cause significant
apoptosis (Fig. S5A-C), suggesting that the effects of the rotenone
and oligomycin treatments were not generally toxic but were more
specifically disruptive in the manifestation of mature villi
(Fig. S5D). Indeed, RT-qPCR on explant tissues reveals that
inhibition of the ETC reduces expression of villus maturation genes
but does not affect proliferating cell markers (Fig. 6J). This is
corroborated by reduced alkaline phosphatase staining upon ETC
inhibition (Fig. 6K). Together, these results indicate that increased
aerobic respiration is indispensable for villus elongation and
maturation of intestinal cells.
NEC patients exhibit a transcriptome deficient in YY1-
dependent genes and diminished inOxPhos gene expression
Underdeveloped intestines are suspected to be a primary cause of
NEC (Neu and Walker, 2011; Zani and Pierro, 2015), but the
molecular etiologies of NEC remain unclear. Given that loss of
YY1 in the developing gut leads to a phenotype reminiscent of
Fig. 3. YY1 is dispensable for the onset of villogenesis; YY1 acts independently of mTOR signaling in regulating villogenesis. (A-D) Immunofluorescent
staining of E16.5 YY1KO intestine shows PDGFRα expression in mesenchymal clusters associated with villogenesis, similar to littermate controls. PECAM1
staining shows thatYy1mutants have similar vascularization as the control. Villogenesis occurs normally upon inhibition of themTOR pathway by genetic ablation
of Rptor (F) or pharmacological inhibition using rapamycin (G), as compared with controls (E) at E18.5. mTOR pathway inhibition by RptorKO and rapamycin
treatment was confirmed by western blot using pS6 antibody (Fig. S3A,B). E18.5 duodenal villi heights in mTOR-inhibited embryos were unchanged compared
with controls (P=0.207, P=0.218). Control or mTOR-inhibited intestines were drastically longer than YY1KO villi heights (as seen in Fig. 1L). Error bars represent
s.e. Two-tailed t-tests were performed based on the results of an F-test for sample variances. Scale bars: 50 µm.
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that of NEC patient bowels, we explored the possibility that NEC
patients exhibit deficiencies in the YY1-dependent transcriptome.
We analyzed expression data from NEC patients compared with
surgical control patients (Chan et al., 2014) using Gene Set
Enrichment Analysis (GSEA). A strong correlation was observed
between genes downregulated in NEC patients and genes
downregulated upon YY1 loss (Fig. 7A). Genes enriched at the
leading edge of this correlation between NEC patients and YY1 loss
were enriched in mitochondrial and brush border gene ontologies
(Fig. 7B), consistent with altered metabolism and poorly matured
intestine in both systems.
To corroborate our findings, we analyzed whether OxPhos genes
were underexpressed in NEC patient samples. We indeed observed
that OxPhos genes are significantly reduced in NEC patients
(Fig. 7C, P=2.20×10−10, Wilcoxon test). Although YY1 target
genes were underexpressed in the NEC patient group, YY1 itself
was unaffected (average expression value of 10.41±0.04 in controls
versus 10.40±0.05 in patients, ±s.d.), suggesting that multiple
pathways are responsible for the diminished OxPhos gene
expression in these patients. Our study thus highlights
deficiencies in aerobic metabolism as a possible underlying
etiology of NEC.
Fig. 4. YY1 loss compromises mitochondrial ultrastructure and gene expression. (A) Experimental workflow to capture the E15.5 epithelial transcriptomes
from control and YY1KO embryos. (B) Eight hundred genes were identified as downregulated (log2 FC>1 and Benjamini-Hochberg adjusted P<0.05) upon YY1
loss, and (C) their enriched ontologies, demonstrating reduced expression of nuclear mitochondrial genes upon YY1 loss. (D,E) Ultrastructural analysis of
enterocytes shows deformedmitochondria (arrows) and significantly stuntedmicrovilli (D, red box; E, *P=0.0467). Error bars represent s.e. Two-tailed t-tests were
performed based on the results of an F-test for sample variances. Scale bars: 0.5 µm.
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There has been a renewed interest in cellular metabolism in recent
years, particularly in the cancer field, where the observation of
Warburg metabolism has undergone a renaissance. Warburg
observed that cancer cells ferment sugar (an inefficient source of
2 ATPs per molecule of glucose), even in the presence of oxygen
(conditions in which differentiated cells can produce 36 molecules
of ATP by metabolizing sugar to CO2 through oxidative
phosphorylation) (Warburg et al., 1924). Recent hypotheses to
explain the Warburg effect have centered upon the fact that biomass
is a key requirement for a growing tissue, and possibly more
important than ATP. Glycolysis provides glycolytic intermediates,
which are the building blocks for amino acids and nucleotides, and
acetyl-CoA for fatty acids (Vander Heiden et al., 2009). Thus, a
growing tissue, be it in a tumor or in a developing embryo, benefits
from the fermentation of sugar to acquire biomass. Our study
identifies an increase in OxPhos genes as the intestine takes on a
more differentiated role. We propose that glycolysis is the preferred
metabolism from E9.5 through E16.5 in order to increase biomass
as the gut is rapidly expanding and as nearly all cells are
proliferative. Then, as cells begin to differentiate on elongated
villi at E17.5, we believe that a shift to oxidative metabolism is
Fig. 5. Failure of oxidative phosphorylation gene expression at the onset of villus elongation in the absence of YY1. (A,B) Developmental timecourse
showing expression of oxidative phosphorylation genes in mouse intestine in CD1 (A) and C57BL/6 (B) genetic backgrounds. (C) Genes downregulated upon
YY1 loss (log2 FC>0.27 and Benjamini-Hochberg adjusted P<0.05, 2475 genes) were analyzed using IPA; the mitochondrial dysfunction canonical pathway
(P=1.02×10−10) is enriched, highlighting YY1-dependent genes involved in all complexes (I-V) of the electron transport chain. Inhibitory targets of mitochondrial
toxins are shown, with rotenone inhibiting complex I and oligomycin inhibiting complex V. (D,E) Mitochondrial activity assays for respiratory chain complex I
(D, NADH-coenzyme Q reductase, blue) and complex IV (E, cytochrome C oxidase, brown) show dramatically reduced activity in Yy1 mutant epithelial cells.
Non-epithelial cells exhibited similar staining in Yy1mutant and controls; also see Fig. S4. (F,G) Tomm20 immunostaining (F) reveals increased but more diffuse
immunoreactivity in the mutants. Elevated Tomm20 protein levels were also observed by immunoblot (G). β-actin is a loading control. Scale bars: 50 µm.
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favored, increasing ATP availability for transporters and enzymes
associated with digestion. Interestingly, we find that enterocyte
differentiation appears more affected than goblet cell
differentiation; this finding might suggest different metabolic
demands for these epithelial cell lineages.
Several recent studies have observed an association between
metabolic state and developmental processes, including in
hematopoietic, mesenchymal and neural lineages (Shyh-Chang
et al., 2013; Ufer and Wang, 2011). In the mature intestine, where
rapid growth in intestinal crypts feeds differentiated cells onto the
villi, it was recently observed that the proliferating progenitor cells
exhibit a more glycolytic metabolism than their differentiated
counterparts (Stringari et al., 2012; Xiong et al., 2015). A key role of
future studies will be to determine whether metabolic states are
dependent on developmental signaling processes, whether
developmental signaling processes depend upon metabolic states,
or most likely an interdependence of the two processes. Along these
lines, interesting recent analyses have placed metabolic control
under the important intestinal WNT signaling pathway (Pate et al.,
2014). We have previously shown that the WNT-dependent adult
intestinal stem cells rely upon YY1 for renewal; whether there is a
relationship between WNT and YY1 in mitochondrial regulation
has not been explored, and YY1-dependent control of stem cell
markers in the developing gut is less clear (Fig. S5E). Another
metabolic regulator, PPARGC1α, has been shown to work as a
co-factor with YY1 in other contexts (Cunningham et al., 2007).
PPARGC1α and its family members are downregulated in the Yy1
embryonic intestinal mutant (Fig. S5F) and could play a role in
mitochondria-dependent villus growth as well.
NEC is a major cause of neonatal mortality but the etiologies
behind NEC are unknown (Neu and Walker, 2011; Zani and Pierro,
2015). Our study found a strong correlation between the
transcriptomes of Yy1 mutants and NEC patients, raising the
possibility that metabolic dysfunction could contribute to NEC.
We also observed that OxPhos genes are downregulated in NEC
patients, which could reflect the often-observed microvascular
defects in NEC intestines, the underdeveloped state of NEC guts, or
could be a primary deficit leading to the NEC phenotype. Our work,
showing that intestinal maturation is compromised by disrupting a
regulator of OxPhos genes or by directly inhibiting the ETC,
Fig. 6. Mitochondrial activity is required for villus development. (A,B) E14.5 explants cultured for 96 h in control and rotenone-supplemented media exhibit a
failure to elaborate villi. Mitochondrial inhibitors did not affect YY1 levels (C-E) or proliferation (F-H), similar to the YY1KO phenotype (Figs 1, 2). (I) Quantification
of villus formation in the explants. *P=0.00096, **P=0.001705, versus control. (J) qRT-PCR shows reduced levels of enterocyte marker transcripts upon treatment
of explants with mitochondrial inhibitors. For statistical analysis, inhibitor treatments were grouped (n=4) and tested against the control (n=3). Epcam, P=0.0564;
villin, P=0.0866; Alpi (intestinal alkaline phosphatase), P=0.00329. (K) Explants treated with rotenone also exhibited decreased alkaline phosphatase activity
compared with controls. Error bars represent s.e. Two-tailed t-tests were performed based on the results of an F-test for sample variances. Scale bars: 50 µm.
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demonstrates that a primary disruption of a metabolic shift can lead
to an NEC-like phenotype. Additionally, our study highlights the
potential impact of environmental toxins on NEC, as we
demonstrate that mitochondrial toxins that are commonly used as
pesticides can elicit an NEC phenotype. Future studies could
explore whether there is a link between the environmental use of
these toxins and NEC incidence.
MATERIALS AND METHODS
Mice
Yy1f/f mice (Affar et al., 2006) and Shh-cremice (Harfe et al., 2004; Harris-
Johnson et al., 2009) were purchased from Jackson Labs and male Shh-cre;
Yy1f/+ mice were bred to Yy1f/+ and Yy1f/f mice for experimental litters. All
mouse protocols and experiments were approved by Rutgers Institutional
Animal Care and Use Committee.
Tissue preparation
For paraffin processing, duodenum, ileum or full small intestine was fixed
overnight in 4% paraformaldehyde at 4°C, washed with PBS, and passed
through increasing concentrations of an ethanol series and paraffin before
embedding. For explant cultures, Histogel (ThermoFisher Scientific, HG-
4000-012) was used during processing and embedding. In the case of tissue
prepared for BrdU immunohistochemistry, the mice were injected with 1 mg
BrdU1 h, 48 h or 96 h before euthanasia. For immunofluorescent stains, E16.5
small intestines were fixed overnight in 4% paraformaldehyde at 4°C, washed
with PBS, then embedded in 7% agarose and Vibratome sectioned at 100 µm.
Rapamycin (LC laboratories, R-5000) treatment was for 5 days beginning
at E13.5 at 5 mg/kg. Rapamycin was dissolved in 100% ethanol, diluted in
5% Tween 80 and 5% PEG 400 (final concentrations). To induce Rptor
knockout, pregnant dams were injected with tamoxifen (1 mg) for 4 days at
beginning E13.5 and harvested at E18.5.
Rapid genotyping
Pregnant dams were sacrificed and dissected embryos were kept in ice-cold
PBS. Embryo tail tissue was used for genotyping using KAPA Mouse
Genotyping Kits (Kapa Biosystems, KK7352).
Immunohistochemistry
Intestinal sections (5 µm cut from paraffin blocks) were processed for
immunostaining with the indicated primary antibodies, developed using the
Vectastain ABC Kit (Vector Laboratories, PK6101) and counterstained
with Hematoxylin. A 1 h antigen-retrieval step in 10 mM sodium citrate
solution under 15 psi pressure was used for all stains. Slides were incubated
in primary antibody overnight at 4°C. Primary antibodies and dilutions used
for staining were: YY1 (Santa Cruz, E0511; 1:500), cleaved caspase 3
(CC3; Cell Signaling, 9661S; 1:200), BrdU (AbD Sterotec, MCA2060GA;
1:500), Tomm20 (Santa Cruz, sc-11415; 1:50) and Ki67 (Abcam, ab15580;
1:300). For cleaved caspase 3, the primary antibody was diluted in the
Signal Stain Ab Diluent (Cell Signaling, 8112S). For periodic acid-Schiff
staining, slides were incubated in 0.5% periodic acid and stained with
Schiff’s reagent (J612171, Alfa Aesar). For alkaline phosphatase staining,
1-Step NBT/BCIP (Thermo Scientific, 34042) was used along with Neutral
Red counterstain. Before developing the alkaline phosphatase, the slides
were incubated in 0.1 M Tris-HCl buffer pH 8.
Images were taken using a Retiga 1300 CCD (Q-Imaging) camera and a
Nikon Eclipse E800 microscope with the QC-Capture imaging software.
Oil was used for 60×/1.4 N.A. magnification and air for 10×/0.45 N.A.,
20×/0.75N.A. and 40×/0.75N.A.Adjustments in contrast and brightness, when
made, were applied uniformly to complete figure panels in Adobe Photoshop.
Vibratome sections were permeabilized in 0.1% Triton X-100 for 25 min,
washed three times for 5 min each with PBS, and blocked with 5% normal
goat serum before primary antibody was added overnight at 4°C. Primary
antibodies were E-cadherin (BD Transduction Labs, 610181; 1:1000),
PECAM1 (CD31; BD Transduction Labs, 557355; 1:1000) and PDGFRα
(Santa Cruz, sc338; 1:200). Sections were thenwashed three times for 15 min
each in blocking solution before DAPI and donkey anti-mouse Alexa 555,
goat anti-rabbit Alexa 488 or goat anti-rat Alexa 647 (all Invitrogen; 1:1000)
secondary antibodieswere added for 1 h at room temperature. Finally, sections
were washed three times for 15 min each in PBS and mounted on slides with
ProLongGold (ThermoFisher Scientific) for confocal imaging on aNikonA1
confocal microscope with Nikon Elements software. Three-dimensional
images were reconstructed using Imaris 8.0.2 software (Bitplane).
Quantification
ImageJ software was used to calculate villi and microvilli length. Only villi
that were complete and protruding from the basement membrane were
considered. Only microvilli with complete longitudinal sections were
measured. For epithelial cell counts (Fig. S2F), 0.2 mm duodenal regions
(E14.5) and 0.663 mm duodenal regions (E18.5) were quantified along one
side of the intestine and then normalized to 1 mm. For explant experiments,
only sections of tissue containing intact epithelium, mesenchyme and the
basement membrane were measured. Regions of growth in explant assays
were characterized as areas with villi protruding above the flat epithelial
layer. Explant experiments were performed five times and multiple counts
were averaged for each biological replicate to measure the region of villus
growth (control n=3, rotenone n=6, oligomycin n=2) and biological
replicates were analyzed for significance using a two-tailed t-test based on
the results of an F-test for sample variances between biological replicates.
For the BrdU pulse-chase experiment (Fig. 2I), the average number of
BrdU-positive cells per villus was determined using immunohistochemistry
and grouped according to BrdU-positive cell position relative to the
Fig. 7. Necrotizing enterocolitis patients exhibit transcriptomes similar to those of Yy1 mutants. (A) GSEA analysis reveals that genes downregulated
upon YY1 loss strongly correlate with genes of reduced expression in NEC patients. (B) Genes at the leading edge of the GSEA, representing those
downregulated in both NEC patients and YY1KO transcriptomes, are enriched in the indicated gene ontologies. (C) Box plot showing that NEC patients exhibit an
overall reduction in oxidative phosphorylation gene expression (Wilcoxon test, *P=2.20×10−10), suggesting a potential contribution to this disease etiology. Data
in C are derived from four NEC patients and four surgical controls (GSE46619).
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intervillus base. (group1, cells up to position 5; group 2, cells in positions 6-
15; group 3, cells in positions 16-25). Averages were taken from up to four
biological replicates of each condition.
Western blot
Whole cell lysate (50 μg) from whole small intestine tissue of control,
rapamycin-treated or RptorKO mice was heat denatured in 5×SDS sample
buffer, separated by 4-12% gradient SDS-PAGE, and transferred onto a
PVDF membrane (Millipore, ISEQ00010). The membrane was blocked
with 5% skimmed milk in PBS containing 0.1% Tween 20 for 1 h, and then
pS6 (Cell Signaling; #4858; 1:1000), Tomm20 (as above; 1:1000) and β-
actin (Abcam; ab8227; 1:5000) antibodies were used to detect proteins.
Microarray
To measure transcriptome differences between E15.5 epithelial cells of Shh-
cre; Yy1f/f andCre-negative Yy1f/f embryos, two biological replicates were used
for each genotype. Each biological replicate included either cells isolated from
one fetal intestine, or cells pooled from two intestines of the same genotype.
Replicates all came from the same litter. Small intestines (proximal stomach to
distal caecum) were dissected and cut into small pieces. Tissue pieces were
then trypsinized with trypsin-EDTA 0.05% (ThermoFisher Scientific, 25300-
054) for 5 min and thenneutralizedwith 10%FBS to isolate single cells. Single
cells were incubated with PE-conjugated anti-CD326 (Epcam clone G8.8,
eBiosciences, 12-5791-81) for 15 min on ice. PE-stained cells were then
incubated for 15 min with magnetic bead-conjugated anti-PE antibody
(Miltenyi Biotec, Anti-PE MicroBeads, 130-048-801). Enriched epithelium
cells were obtained by passing cells through a column (Miltenyi Biotec, MS
Columns, 130-042-201) in a magnetic field to obtain Epcam-positive,
magnetic antibody-conjugated cells. Cells were then dissolved in Trizol and
RNA prepared by ethanol precipitation using 10 μg linear polyacrylamide
(LPA; Sigma-Aldrich). RNAwas then processed formicroarray onAffymetrix
Mouse 430_2 arrays according to manufacturer’s instructions. Data were
analyzed using R Bioconductor (Gentleman et al., 2004) with gcrma
normalization (Wu et al., 2004) and the limma package (Smyth, 2004).
1495 unique genes were differentially expressed with log2 FC >1 and
Benjamini-Hochberg adjustedP<0.05 (Table S1); 800 geneswere identified as
downregulated (log2 FC<−1 and Benjamini-Hochberg adjusted P<0.05) and
were analyzed for gene ontology using DAVID (Dennis et al., 2003).
TEM
Intestinal tissues were dissected, flushed in cold PBS, minced into 1-3 mm
fragments and fixed overnight at 4°C in 0.1 M sodium cacodylate buffer
(pH 7.4) containing 2.5% glutaraldehyde and 2.0% (vol/vol)
paraformaldehyde. Fixed tissues were washed briefly with 0.1 M sodium
cacodylate buffer and postfixed with 1% osmium tetroxide in 0.1 M sodium
cacodylate buffer for 1 h at 4°C. Tissues were washed with excess distilled
water and en bloc-stained with 1% aqueous uranyl acetate for 30 min in the
dark. Tissues were then washed with distilled water and dehydrated through
a series of ethanol and propylene oxide. Tissues were then transferred into
EMBed 812 (Electron Microscopy Sciences, 14120) and propylene oxide
(mixed at 1:1) overnight at room temperature in tightly capped vials on a
shaker. Tissues were then transferred into 100% EMBed 812 (Electron
Microscopy Sciences) overnight at room temperature. Tissues were
embedded in embedding molds at 65°C for two nights. Ultrathin sections
(70 nm) were cut; grids were stained with uranyl acetate and lead citrate and
observed under an FEI Tecnai 12 transmission electron microscope with a
Gatan cooled CCD camera. Multiple grids were analyzed for each intestinal
sample. The image was adjusted in Adobe Photoshop using the hue/
saturation adjustment tool to +7, the brightness and contrast adjustment tool
to +28 and +7, respectively, and finally selecting ‘increase contrast 1’ using
the levels adjustment tool.
Informatics analysis
Genes involved in oxidative phosphorylation (135 genes) were obtained
from the GSEA-KEGG oxidative phosphorylation list (Liberzon et al.,
2011; Kanehisa et al., 2016; Kanehisa and Goto, 2000). Those involved in
lysosomal ontologies (23 genes), not directly implicated in oxidative
phosphorylation, were omitted to obtain a final oxidative phosphorylation
gene list (112 genes) (Table S1). A custom R script was used to prepare
heatmaps of oxidative phosphorylation gene expression in mouse colon of
CD1 and C57BL/6 genetic backgrounds (GSE5204) (Kaiser et al., 2007).
NEC patient microarray CEL files (GSE46619) were obtained from a
previous study in which whole-genome microarray expression profiling was
performed on bowel tissue from neonates diagnosed with NEC and surgical
controls (Chan et al., 2014). We processed the CEL files using R
Bioconductor (Gentleman et al., 2004) with gcrma normalization (Wu
et al., 2004) and the limma package (Smyth, 2004). Principal component
analysis and hierarchical clustering were performed as quality control, and
one replicate found to be an outlier was omitted from further analysis. Our
study analyzed four biological NEC replicates and four surgical controls.
Genes downregulated in NEC patients were analyzed using DAVID (Dennis
et al., 2003). Correlation study of NEC patients and YY1 downregulated
genes was performed using GSEA (scoring scheme, weighted;
permutations, 10,000) (Subramanian et al., 2005). NEC patient log2 FC of
oxidative phosphorylation genes and all genes was calculated andWilcoxon
test used to evaluate statistical significance using a custom R script. A
schematic of oxidative phosphorylation genes dependent on YY1 was
prepared by modifying the pathway workflow obtained from IPA
(www.qiagen.com/ingenuity) using genes downregulated upon YY1 loss
(log2 FC<−0.27 and Benjamini-Hochberg adjusted P<0.05, 2475 genes).
YY1 ChIP-seq peaks were obtained from a previous study that identified
YY1 binding sites in adult intestinal epithelium (GSM1295000) (Perekatt
et al., 2014). Genes within 30 kb regions of YY1 binding sites were
overlapped with genes downregulated in intestinal epithelium upon YY1
loss (log2 FC<−0.27 and Benjamini-Hochberg adjusted P<0.05, Table S1).
Mitochondrial activity assays
Complex I (NADH dehydrogenase-NADH coenzyme Q reductase complex)
activity was assessed for mouse cryosections using previously described
methods (Christensen and Diemer, 2003; Hench et al., 2011). In brief, flash-
frozen tissues were prepared for cryosection (4 μm). Sections were covered
with reaction medium [0.2 M Tris buffer pH 7.4 containing 1 mg/ml
tetranitroblue tetrazolium (NBT), 5 mM MgCl2, 25 mM CoCl2 and 2 mg/ml
NADH] at room temperature. After development of the blue color (8-10 min)
the reaction was stopped using 4% formalin (10-15 min), then washed twice
with distilled water and mounted in water-based mounting medium. Complex
IV (cytochrome C oxidase) activity was assessed as previously described
(Seligman et al., 1968). Briefly, cryosections (4 μm) were incubated in
reaction buffer [2.5 ml 0.2 M phosphate buffer pH 7.6, 20 mg catalase, 10 mg
cytochrome c, 5 mg3,3′-diaminobenzidine tetrahydrochloride hydrate (DAB)
and 750 mg sucrose in 7.5 ml deionized water] for 1 h, rinsed three times with
water, dehydrated and mounted in xylene-based mounting medium.
Explants
Proximal duodena were dissected from E14.5 and E15.5 embryos,
connective tissue was separated, and intestines were placed on Transwell
membrane (Costar, 3428) in BGJb medium (Invitrogen, 12591-038)
supplemented with 1% pen/strep (vol/vol) and 0.1 mg/ml ascorbic acid
(Sigma, A4403). For mitochondrial inhibition, base medium was
supplemented with 1 µM rotenone (Sigma, 45656) or 1 µM oligomycin
(Sigma, O4876). Intestines were cultured for 72 h (starting at E15.5) or 96 h
(starting at E14.5) at 37°C with 5% CO2 with medium changes every 24 h.
For qPCR analysis, intestinal explants were cultured for 48 h (starting at
E15.5). Tissue was dissolved in Trizol and RNA prepared using the RNeasy
Micro Kit (Qiagen, 74004). The RNA was reverse transcribed using the
SuperScript III First-Strand Synthesis System (Invitrogen, 18080051) to
prepare cDNA for qPCR analysis using gene-specific primers and SYBR
Green PCR Master Mix (Applied Biosystems, 4309155).
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